Case Studies

1. From Variability To Validation – GMP Bioassay Success Through Partnership 2/27/2026

   Turn your inconsistent bioassays into GMP-validated, high-reliability platforms — just like we helped a biopharma partner cut failure rates from ~25% to <1%.

2. Case Study: The Right Ratio – Building An End-To-End DAR Strategy For ADC Success 2/27/2026

   When developing antibody-drug conjugates (ADCs), a robust drug-to-antibody ration (DAR) strategy isn’t just nice to have — it's mission-critical.